| 1 |
Lv C, He N, Yang JJ, Xiao JJ, Zhang Y, Du J, Zuo S, Li HY, Gu H. Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study. Br J Radiol 2023;:20220702. [PMID: 36745047 DOI: 10.1259/bjr.20220702] [Reference Citation Analysis]
|
| 2 |
Li J, Yang F, Li J, Huang ZY, Cheng Q, Zhang EL. Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion. World J Gastrointest Surg 2023; 15(1): 19-31 [DOI: 10.4240/wjgs.v15.i1.19] [Reference Citation Analysis]
|
| 3 |
Wang W, Li J, Liang B, Lv X, Zhu R, Wang J, Huang Z, Yang S, Zhang E. Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study. Front Oncol 2022;12:980736. [DOI: 10.3389/fonc.2022.980736] [Reference Citation Analysis]
|
| 4 |
Liu L, Liu Z, Gao J, Liu X, Weng S, Guo C, Hu B, Wang Z, Zhang J, Shi J, Guo W, Zhang S. CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma. Front Immunol 2022;13:964190. [DOI: 10.3389/fimmu.2022.964190] [Reference Citation Analysis]
|
| 5 |
Qiu Y, Yang Y, Wang T, Shen S, Wang W. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion. Front Oncol 2022;12:831614. [DOI: 10.3389/fonc.2022.831614] [Reference Citation Analysis]
|
| 6 |
Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know? JHC 2022;Volume 9:379-87. [DOI: 10.2147/jhc.s364742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Chen Y, Qiao H, Lian Z, Li C, Xiang Y. Diagnostic accuracy of contrast-enhanced ultrasound for microvascular invasion of hepatocellular carcinoma: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e29083. [PMID: 35475795 DOI: 10.1097/MD.0000000000029083] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Xia F, Zhu P, Chen XP, Zhang BX, Zhang MY. Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis. J Oncol 2022;2022:7531452. [PMID: 35342424 DOI: 10.1155/2022/7531452] [Reference Citation Analysis]
|
| 9 |
Guo X, Zhang W, Du J, Tao R, Dong W, Huang J, Zhang J, Pan Z, Zhou W, Zhu X, Liu H, Liu F. Acute-Phase Serum Amyloid A May Predict Microvascular Invasion and Early Tumor Recurrence in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Liver Resection. J Invest Surg 2022;:1-9. [PMID: 35143736 DOI: 10.1080/08941939.2022.2035858] [Reference Citation Analysis]
|
| 10 |
Dong S, Wang W, Chen X, Yang Y, Zhu S, Zeng M, Rao S. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI. Eur Radiol. [DOI: 10.1007/s00330-021-08495-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Sharbidre KG. Editorial Comment: Recurrence of Hepatocellular Carcinoma in Liver Transplants-Microvascular Invasion and Pathologic Staging of the Explant Liver. AJR Am J Roentgenol 2022;218:87. [PMID: 34406063 DOI: 10.2214/AJR.21.26681] [Reference Citation Analysis]
|
